Your browser doesn't support javascript.
loading
A comprehensive gene expression profile analysis of prostate cancer cells resistant to paclitaxel and the potent target to reverse resistance.
Che, Ping; Jiang, Shihao; Zhang, Weiyang; Zhu, Huixuan; Hu, Daorong; Wang, Delin.
Afiliação
  • Che P; Department of Urology, 117972The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Jiang S; Department of Pediatric Surgery, Maternity and Child Health Hospital of Chongqing Hechuan, Chongqing, China.
  • Zhang W; Department of Urology, 117972The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zhu H; Department of Urology, 117972The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Hu D; Department of Urology, 117972The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Wang D; Department of Urology, 573428People's Hospital of Chongqing Hechuan, Chongqing, China.
Hum Exp Toxicol ; 41: 9603271221129854, 2022.
Article em En | MEDLINE | ID: mdl-36165000

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Fitogênicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Fitogênicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article